Funding Status: Early Stage Venture
Headquarters: Somerville, Massachusetts, United States
Total Funding: 420000000.0
Last Funding Date: 2021-11-18
Investors Number: 8.0
Founded Date: 2018-01-01
Industry: Early Drug Development
Last Funding Type: Series B
Employee Number: 11-50